C12N 2770/10041
Use of virus, viral particle or viral elements as a vector
C12N2770/10041 (Use of virus, viral particle or viral elements as a vector) appears on 25 US grants and 31 published applications in this corpus.
Search patents in C12N- Granted patents
- 25
- Published applications
- 31
- Assignees
- 15
- Inventors
- 45
- Latest grant
- 4 Nov 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2002 | 1 | 1 |
| 2003 | 0 | 1 |
| 2004 | 0 | 0 |
| 2005 | 0 | 0 |
| 2006 | 0 | 2 |
| 2007 | 1 | 1 |
| 2008 | 0 | 1 |
| 2009 | 1 | 1 |
| 2010 | 1 | 4 |
| 2011 | 1 | 2 |
| 2012 | 2 | 1 |
| 2013 | 3 | 0 |
| 2014 | 2 | 1 |
| 2015 | 1 | 2 |
| 2016 | 0 | 1 |
| 2017 | 1 | 3 |
| 2018 | 1 | 0 |
| 2019 | 1 | 1 |
| 2020 | 2 | 2 |
| 2021 | 0 | 1 |
| 2022 | 1 | 1 |
| 2023 | 2 | 2 |
| 2024 | 2 | 1 |
| 2025 | 2 | 0 |
| 2026 | 0 | 2 |
By publication year. 2026 runs to 8 Oct.
Subgroups
Granted patents
- C12N 2770/10043Viral genome or elements thereof as genetic vectorIndexing code25
- C12N 2770/10042Virus or viral particle as vehicleIndexing code0
- C12N 2770/10044Chimeric viral vector comprising heterologous viral elements for production of another viralIndexing code0
- C12N 2770/10045Special targeting system for viral vectorsIndexing code0
Recent patents
- Recombinant arterivirus replicon systems and uses thereof4 Nov 2025US 12,460,229 B2Janssen Pharmaceuticals, Inc.
- Porcine circovirus type 3 (PCV3) vaccines, and production and uses thereof7 Oct 2025US 12,433,942 B2
- North American porcine reproductive and respiratory syndrome (PRRS) virus and uses thereof20 Feb 2024US 11,904,011 B2Zoetis Services LLC
- Porcine Circovirus Type 3 (PCV3) vaccines, and production and uses thereof13 Feb 2024US 11,896,659 B2
- Porcine Circovirus Type 3 (PCV3) vaccines, and production and uses thereof18 Jul 2023US 11,701,419 B2
- Nadc34-like prrsv-2 vaccine candidate strain and application thereof2 Apr 2026US 2026/0091100 A1Yangzhou University
- Porcine Circovirus Type 3 (PCV3) Vaccines, and Production and Uses Thereof12 Mar 2026US 2026/0069672 A1Boehringer Ingelheim Vetmedica GmbH
- Porcine Circovirus Type 3 (PCV3) Vaccines, and Production and Uses Thereof11 Jul 2024US 2024/0226264 A1Boehringer Ingelheim Vetmedica GmbH
- Porcine Circovirus Type 3 (PCV3) Vaccines, and Production and Uses Thereof28 Sep 2023US 2023/0302113 A1Boehringer Ingelheim Animal Health USA Inc.
- Recombinant arterivirus replicon systems and uses thereof20 Jul 2023US 2023/0227850 A1Janssen Pharmaceuticals, Inc.
Most cited
By later US patents
- Infectious cDNA clone of North American porcine reproductive and respiratory syndrome (PRRS) virus and uses thereof55US 6,500,662 B1Pfizer Inc. · 2002
- Infectious cDNA clone of North American porcine reproductive and respiratory syndrome (PRRS) virus and uses thereof31US 7,232,680 B2Pfizer Inc. · 2007
- Infectious cDNA clone of north american porcine reproductive and respiratory syndrome (PRRS) virus and uses thereof26US 7,691,389 B2Pfizer Inc. · 2010
- Infectious cDNA clone of North American porcine reproductive and respiratory syndrome (PRRS) virus and uses thereof24US 7,618,797 B2Pfizer Inc. · 2009
- PRRS viruses, infectious clones, mutants thereof, and methods of use17US 8,110,390 B2Regents of the University of Minnesota · 2012